---
{"dg-publish":true,"permalink":"/metaanalysis-and-revman-5-questions-resolutions-and-important-links/"}
---


### 1 Link 

1. **Como fazer um update de uma revisão sistemática?** https://www.bmj.com/content/354/bmj.i3507
2. **Estatística nos updates de revisões sistemáticas?** [Ver estes vídeos](https://training.cochrane.org/resource/statistical-methods-updating-meta-analyses)
3. **Como usar o RevMan5?** [Ver vídeo](https://www.youtube.com/watch?v=O4NXGYe_yd4&ab_channel=CochraneTraining)
4. **Checklist PRISMA** [Ver vídeo](https://www.youtube.com/watch?v=fr-mMDJib4Y&ab_channel=ResearchMedicalLibrary) [Download](https://www.prisma-statement.org/) [Expanded Checklist](https://www.prisma-statement.org/documents/PRISMA_2020_expanded_checklist.pdf)
5. **PRISMA diagram** [Onde fazer](https://www.eshackathon.org/software/PRISMA2020.html](https://www.eshackathon.org/software/PRISMA2020.html)
6. **Registo da meta-análise na plataforma PROSPERO**
7. **Explicação step-by-step PRISMA** [documento](https://www.bmj.com/content/372/bmj.n160)
8. **Site para a pesquisa dos textos** [Site](https://get.covidence.org/literature-review?campaignid=18165361407&adgroupid=138405766537&gclid=Cj0KCQiA4uCcBhDdARIsAH5jyUl4g1oS9EBC8z9YuolSM5PYBwhTL_DN8t1jona_M3RVBzlvabZM1A0aAmxpEALw_wcB)

### 2 Dentro do RevMan5
1. **Como transformar IQR em SD?** [link](https://www.researchgate.net/post/Is_there_any_way_to_get_mean_and_SD_from_median_and_IQR_interquartile_range)
2. **Pooled groups** [link](https://dmetar.protectlab.org/reference/pool.groups.html)
3. **Combinar dicotómica com contínua** [handbook](https://handbook-5-1.cochrane.org/chapter_9/9_4_6_combining_dichotomous_and_continuous_outcomes.htm)
4. **Importante para analises com mais de um grupo** [16.5.2 Determining which intervention groups are relevant (cochrane.org)](https://handbook-5-1.cochrane.org/chapter_16/16_5_2_determining_which_intervention_groups_are_relevant.htm)
5. **Effect measures for ordinal outcomes and measurement scales** [link](https://handbook-5-1.cochrane.org/chapter_9/9_2_4_effect_measures_for_ordinal_outcomes_and_measurement.htm)
6. **Contagem de efeitos secundários** [handbook](https://handbook-5-1.cochrane.org/chapter_9/9_4_8_meta_analysis_of_counts_and_rates.htm) 
7. **What to do when there are 0 cell counts?** [handbook](https://handbook-5-1.cochrane.org/chapter_16/16_9_2_studies_with_zero_cell_counts.htm) Quick answer, there's no problem, RevMan will change the value to 0.5
8. **What to do when there are no events?** do note include in the study [handbook](https://handbook-5-1.cochrane.org/chapter_16/16_9_3_studies_with_no_events.htm)
9. **Heterogenity** https://handbook-5-1.cochrane.org/chapter_9/9_5_3_strategies_for_addressing_heterogeneity.htm
10. **Calculate RR, OR and RateRatio** [handbook](https://www.youtube.com/watch?v=4Iq_78hNfBU&ab_channel=CochraneTraining)
11. **Combine dichotomous and continuous variables** [handbook](https://handbook-5-1.cochrane.org/chapter_9/9_4_6_combining_dichotomous_and_continuous_outcomes.htm)
12. **Mixed model analysis explanation**[youtube](https://www.youtube.com/watch?v=4bGG02Jsjyc&t=570s&ab_channel=TileStats)
13. **How to present risk of bias tables and figures (old version)**: [youtube](https://www.youtube.com/watch?v=kFXzUK6z5L8&ab_channel=JunXia)



### 3 Extras
1. **Duvidas, questões e como realizar a metaanálise** [guide](https://.org/MathiasHarrer/Doing_Meta_Analysis_in_R/effects.html)
- [Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range - PMC (nih.gov)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383202/)

- We're using rate ratio's: https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/1471-2288-4-17

2. **Global rating of change questionnaire: how to find MCID
### 4 Doing the meta-analysis: Considerations

> [!Important]- 1. Pooling results in continuous outcomes
> 
> When outcomes are continuous, review authors have a number of options in presenting pooled results.  If all studies have used the same units, a meta-analysis may generate a pooled estimate in those units, as a difference in mean response (see, for instance, the row summarizing results for oedema in Chapter 11,.  The units of such outcomes may be difficult to interpret, particularly when they relate to rating scales.  **‘Summary of findings’ tables should include the minimum and maximum of the scale of measurement, and the direction**. Knowledge of the smallest change in instrument score that patients perceive is important – the minimal important difference – and can greatly facilitate the interpretation of results.  **Knowing the minimal important difference allows authors and users to place results in context, and authors should state the minimal important difference – if known – in the Comments column of their ‘Summary of findings’ table**.





#### 4.1 Final

read this part before drawing conclusions 
https://training.cochrane.org/handbook/current/chapter-15